Distinctive abnormalities of motor axonal strength-duration properties in multifocal motor neuropathy and in motor neurone disease

A. Priori, C. Cinnante, A. Pesenti, M. Carpo, A. Cappellari, E. Nobile-Orazio, G. Scarlato, S. Barbieri

Research output: Contribution to journalArticle

Abstract

The strength-duration function is a classic measure of neural excitability. When studied on peripheral motor axons it reflects the intrinsic nodal membrane properties, and its time-constant (τSD or chronaxie) predominantly depends on non-voltage-gated, rest Na+ inward conductances. We assessed the strength-duration curve of ulnar motor axons in 22 nerves of healthy controls, in 18 nerves of patients with multifocal motor neuropathy with conduction blocks (MMN), and in 19 nerves of patients with motor neurone disease (MND). The compound muscle action potential (CMAP) was smaller in nerves of both groups of patients than in controls (P <0.05). The rheobasic current (rh50%) [mean ± standard deviation (SD)] was higher in patients with MMN than in controls (13.3 ± 16.3 mA; controls 4.7 ± 1.7 mA, P <0.05). The τSD was differentially abnormal in the nerves of the two groups of patients: it was prolonged in the nerves of patients with MND for ≥40 years (227.2 ± 34.5 μs; controls 190.9 ± 51.0 μs, P <0.05), but it was shortened in the nerves of patients with MMN (146.5 ± 55.4 μs; controls 208.6 ± 51.2 μs, P <0.05) who had not been treated recently with high-dose intravenous immunoglobulin (IVIg). Nerves of patients with recently treated MMN (SD. Our results suggest that, probably due to an immuno-mediated rest Na+ channel dysfunction, Na+ conductances are reduced in MMN. This abnormality is a function of the time after the last IVIg treatment and involves also the axonal membrane outside the conduction block. Conversely, in MND, possibly owing to the ionic leakage of degenerating membrane, rest Na+ conductances are increased. Measuring the strength-duration curve of the ulnar motor axons might be useful in the differential diagnosis between de novo MMN and MND.

Original languageEnglish
Pages (from-to)2481-2490
Number of pages10
JournalBrain
Volume125
Issue number11
Publication statusPublished - Nov 1 2002

Fingerprint

Motor Neuron Disease
Axons
Intravenous Immunoglobulins
Membranes
Chronaxy
Action Potentials
Differential Diagnosis
Muscles

Keywords

  • Motor axons
  • Motor neurone disease
  • Multifocal motor neuropathy with conduction block
  • Rheobase
  • Time constant

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Distinctive abnormalities of motor axonal strength-duration properties in multifocal motor neuropathy and in motor neurone disease. / Priori, A.; Cinnante, C.; Pesenti, A.; Carpo, M.; Cappellari, A.; Nobile-Orazio, E.; Scarlato, G.; Barbieri, S.

In: Brain, Vol. 125, No. 11, 01.11.2002, p. 2481-2490.

Research output: Contribution to journalArticle

@article{cf40ab464a934c1791e0a7da91567be7,
title = "Distinctive abnormalities of motor axonal strength-duration properties in multifocal motor neuropathy and in motor neurone disease",
abstract = "The strength-duration function is a classic measure of neural excitability. When studied on peripheral motor axons it reflects the intrinsic nodal membrane properties, and its time-constant (τSD or chronaxie) predominantly depends on non-voltage-gated, rest Na+ inward conductances. We assessed the strength-duration curve of ulnar motor axons in 22 nerves of healthy controls, in 18 nerves of patients with multifocal motor neuropathy with conduction blocks (MMN), and in 19 nerves of patients with motor neurone disease (MND). The compound muscle action potential (CMAP) was smaller in nerves of both groups of patients than in controls (P <0.05). The rheobasic current (rh50{\%}) [mean ± standard deviation (SD)] was higher in patients with MMN than in controls (13.3 ± 16.3 mA; controls 4.7 ± 1.7 mA, P <0.05). The τSD was differentially abnormal in the nerves of the two groups of patients: it was prolonged in the nerves of patients with MND for ≥40 years (227.2 ± 34.5 μs; controls 190.9 ± 51.0 μs, P <0.05), but it was shortened in the nerves of patients with MMN (146.5 ± 55.4 μs; controls 208.6 ± 51.2 μs, P <0.05) who had not been treated recently with high-dose intravenous immunoglobulin (IVIg). Nerves of patients with recently treated MMN (SD. Our results suggest that, probably due to an immuno-mediated rest Na+ channel dysfunction, Na+ conductances are reduced in MMN. This abnormality is a function of the time after the last IVIg treatment and involves also the axonal membrane outside the conduction block. Conversely, in MND, possibly owing to the ionic leakage of degenerating membrane, rest Na+ conductances are increased. Measuring the strength-duration curve of the ulnar motor axons might be useful in the differential diagnosis between de novo MMN and MND.",
keywords = "Motor axons, Motor neurone disease, Multifocal motor neuropathy with conduction block, Rheobase, Time constant",
author = "A. Priori and C. Cinnante and A. Pesenti and M. Carpo and A. Cappellari and E. Nobile-Orazio and G. Scarlato and S. Barbieri",
year = "2002",
month = "11",
day = "1",
language = "English",
volume = "125",
pages = "2481--2490",
journal = "Brain",
issn = "0006-8950",
publisher = "Oxford University Press",
number = "11",

}

TY - JOUR

T1 - Distinctive abnormalities of motor axonal strength-duration properties in multifocal motor neuropathy and in motor neurone disease

AU - Priori, A.

AU - Cinnante, C.

AU - Pesenti, A.

AU - Carpo, M.

AU - Cappellari, A.

AU - Nobile-Orazio, E.

AU - Scarlato, G.

AU - Barbieri, S.

PY - 2002/11/1

Y1 - 2002/11/1

N2 - The strength-duration function is a classic measure of neural excitability. When studied on peripheral motor axons it reflects the intrinsic nodal membrane properties, and its time-constant (τSD or chronaxie) predominantly depends on non-voltage-gated, rest Na+ inward conductances. We assessed the strength-duration curve of ulnar motor axons in 22 nerves of healthy controls, in 18 nerves of patients with multifocal motor neuropathy with conduction blocks (MMN), and in 19 nerves of patients with motor neurone disease (MND). The compound muscle action potential (CMAP) was smaller in nerves of both groups of patients than in controls (P <0.05). The rheobasic current (rh50%) [mean ± standard deviation (SD)] was higher in patients with MMN than in controls (13.3 ± 16.3 mA; controls 4.7 ± 1.7 mA, P <0.05). The τSD was differentially abnormal in the nerves of the two groups of patients: it was prolonged in the nerves of patients with MND for ≥40 years (227.2 ± 34.5 μs; controls 190.9 ± 51.0 μs, P <0.05), but it was shortened in the nerves of patients with MMN (146.5 ± 55.4 μs; controls 208.6 ± 51.2 μs, P <0.05) who had not been treated recently with high-dose intravenous immunoglobulin (IVIg). Nerves of patients with recently treated MMN (SD. Our results suggest that, probably due to an immuno-mediated rest Na+ channel dysfunction, Na+ conductances are reduced in MMN. This abnormality is a function of the time after the last IVIg treatment and involves also the axonal membrane outside the conduction block. Conversely, in MND, possibly owing to the ionic leakage of degenerating membrane, rest Na+ conductances are increased. Measuring the strength-duration curve of the ulnar motor axons might be useful in the differential diagnosis between de novo MMN and MND.

AB - The strength-duration function is a classic measure of neural excitability. When studied on peripheral motor axons it reflects the intrinsic nodal membrane properties, and its time-constant (τSD or chronaxie) predominantly depends on non-voltage-gated, rest Na+ inward conductances. We assessed the strength-duration curve of ulnar motor axons in 22 nerves of healthy controls, in 18 nerves of patients with multifocal motor neuropathy with conduction blocks (MMN), and in 19 nerves of patients with motor neurone disease (MND). The compound muscle action potential (CMAP) was smaller in nerves of both groups of patients than in controls (P <0.05). The rheobasic current (rh50%) [mean ± standard deviation (SD)] was higher in patients with MMN than in controls (13.3 ± 16.3 mA; controls 4.7 ± 1.7 mA, P <0.05). The τSD was differentially abnormal in the nerves of the two groups of patients: it was prolonged in the nerves of patients with MND for ≥40 years (227.2 ± 34.5 μs; controls 190.9 ± 51.0 μs, P <0.05), but it was shortened in the nerves of patients with MMN (146.5 ± 55.4 μs; controls 208.6 ± 51.2 μs, P <0.05) who had not been treated recently with high-dose intravenous immunoglobulin (IVIg). Nerves of patients with recently treated MMN (SD. Our results suggest that, probably due to an immuno-mediated rest Na+ channel dysfunction, Na+ conductances are reduced in MMN. This abnormality is a function of the time after the last IVIg treatment and involves also the axonal membrane outside the conduction block. Conversely, in MND, possibly owing to the ionic leakage of degenerating membrane, rest Na+ conductances are increased. Measuring the strength-duration curve of the ulnar motor axons might be useful in the differential diagnosis between de novo MMN and MND.

KW - Motor axons

KW - Motor neurone disease

KW - Multifocal motor neuropathy with conduction block

KW - Rheobase

KW - Time constant

UR - http://www.scopus.com/inward/record.url?scp=0036844866&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036844866&partnerID=8YFLogxK

M3 - Article

C2 - 12390974

AN - SCOPUS:0036844866

VL - 125

SP - 2481

EP - 2490

JO - Brain

JF - Brain

SN - 0006-8950

IS - 11

ER -